NADOLOL ELIMINATION BY PATIENTS WITH RENAL IMPAIRMENT

dc.contributor.authorVUKOVICH, RA
dc.contributor.authorHERRERA, JOSE MANUEL DE
dc.contributor.authorGRIFFITH, DL
dc.date.accessioned2026-05-28T16:52:54Z
dc.date.issued1978
dc.description.paginacion133 - 133
dc.description.procedenciaEXT
dc.format.discursoResumen de reunión
dc.format.extent1
dc.identifier.issn0009-9236
dc.identifier.urihttps://ahcm.cinvestav.mx/handle/ahcm/29121
dc.language.isoInglés
dc.numero.secuencia29118
dc.publisherSQUIBB INST MED RES,PRINCETON,NJ 08540
dc.publisherNATL INST NUTR,MEXICO CITY,MEXICO
dc.relation.ispartofseriesVol. 23 No. 1
dc.source.revistafuenteCLINICAL PHARMACOLOGY & THERAPEUTICS
dc.subjectNADOLOL, PATIENTS, RENAL IMPAIRMENT
dc.subject.categoriaprincipalCIENCIAS MEDICAS
dc.subject.disciplinaFARMACOLOGIA
dc.subject.subdisciplinaFARMACOLOGIA EXPERIMENTAL
dc.titleNADOLOL ELIMINATION BY PATIENTS WITH RENAL IMPAIRMENT
dc.title.alternativeCLIN PHARMACOL THER

Files